IMAX (IMAX) is back in focus after Mann Theatres decided to install the first IMAX auditorium at its Plymouth Grand 15 site in Minnesota, along with upcoming IMAX investor conference appearances.

IMAX shares have pulled back slightly in the last week, yet the stock still shows strong momentum with a 30 day share price return of 16.96% and a year to date share price return of 46.47%, alongside a 1 year total shareholder return of 82.18%. This suggests recent deals and upcoming conference appearances are being viewed as meaningful for the longer term story.

Compare IMAX's recent momentum with hand picked big screen and media plays by scanning the 20 high quality undiscovered gems that are still flying under most investors' radar.

IMAX now trades almost exactly in line with the average analyst target, while one intrinsic value estimate still points to a discount. After this sharp run, which reference point does the current price really line up with?

Most Popular Narrative: 10% Overvalued

IMAX last closed at $52.76, which sits slightly above the most followed fair value estimate of $52.73 that uses an 8.89% discount rate. That small gap raises a simple question for investors. How much belief do you place in the growth and margin path that underpins that target.

Diversification of content offerings, including local-language blockbusters, alternative content (concerts, live events), and deeper relationships with streaming and tech partners like Apple, Amazon, and Netflix, is broadening IMAX's audience base and improving margin mix, contributing to higher contribution per screen and more resilient earnings.

There is a detailed earnings roadmap behind that price tag. It leans on faster profit growth than revenue, a richer margin profile, and a premium earnings multiple that outpaces the wider entertainment sector. Curious which assumptions really carry the weight in this narrative.

Result: Fair Value of $52.73 (OVERVALUED)

However, IMAX investors still need to weigh risks such as softer film slates or weaker theater attendance, which could pressure box-office-linked revenue and margins.

Another Take: IMAX Through The SWS DCF Lens

While the analyst fair value for IMAX points to the stock being about 10% overvalued, the SWS DCF model currently suggests a fair value of $58.13. That is roughly a 9% premium to the $52.76 share price. Which set of assumptions do you trust more for the long haul?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out IMAX for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mix of optimism and concern around IMAX feels finely balanced, this is a good moment to look closer. Decide quickly where you stand based on the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond IMAX?

Do not stop your research with IMAX. Use the Simply Wall Street Screener to quickly spot other opportunities that might suit your goals and risk tolerance.

• Target potential mispriced opportunities by scanning a curated 51 high quality undervalued stocks that balance quality with attractive valuations.
• Prioritise resilience by reviewing a list of solid balance sheet and fundamentals (51 results) that can better handle tough periods.
• Reduce portfolio stress by focusing on a 75 resilient stocks with low risk scores that aims for steadier returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.